Covid is still here, among us, though not as severe as in the pandemics. Severity of Covid is linked to fluctuations in blood pressure, the Japanese researchers found. Below is the scientific answer to the much discussed question, can Covid cause high blood pressure.
The study “Association between blood pressure and COVID-19 severity,” was conducted by Dr. Fumiki Yoshihara. It was published in the Journal of the Japanese Society of Hypertension. It has provided valuable insights into the relationship between blood pressure and the severity of COVID-19. The study addressed concerns about the potential impact of increased blood pressure on cardiovascular events in patients with COVID-19.
Significance of the study
The findings of the study are significant. They revealed that preexisting hypertension was associated with critical outcomes in COVID-19 patients. Moreover, in patients without preexisting hypertension, but high blood pressure at admission, were also associated with critical outcomes. This emphasizes the importance of assessing the risk of critical outcomes when initiating the treatment of COVID-19 patients.
So, can Covid cause high blood pressure? The study delved into the mechanisms of blood pressure elevation. These included the impact of renin-angiotensin system (RAS) inhibitors on COVID-19 severity. Also, researches looked at potential influence of sex differences on the efficacy of RAS inhibitors. Furthermore, the study addressed unclarified issues in the association between blood pressure and COVID-19 severity. Race, ethnicity, virus mutant strains, antihypertensive drugs, treatments for COVID-19, and vaccination status, were studied.
The study emphasized the need for further research to clarify the relationship between hypertension, blood pressure, and COVID-19 outcomes, as well as the importance of addressing these unclarified issues to enhance the understanding of this association and improve the management of COVID-19 patients.
The findings of this study contribute to the growing body of knowledge on the impact of blood pressure on COVID-19 severity and provide valuable insights for healthcare professionals involved in the care of COVID-19 patients.
The study’s publication in the Journal of the Japanese Society of Hypertension reflects its contribution to the scientific literature on hypertension and COVID-19. The comprehensive analysis and significant findings make it a valuable addition to the existing body of research on the topic. The study’s findings have implications for clinical practice and the ongoing research efforts to enhance the understanding of this association.
Other studies on COVID and blood pressure
- COVID-19 and New-Onset High Blood Pressure: This study by the American Heart Association found a significant association between COVID-19 and the development of persistent high blood pressure, particularly among hospitalized individuals. Read more.
- Impact of COVID-19 on Blood Pressure: A report by Cleveland Clinic discusses the slight but significant increases in blood pressure observed during the pandemic and emphasizes the importance of blood pressure management. Read more.
- Hypertension and COVID-19: A study published on PubMed examines the role of hypertension as a risk factor for severe COVID-19 outcomes, analyzing how high blood pressure impacts the disease’s progression. Read more.
- Blood Pressure Changes in US Adults During COVID-19: This NIH study observes a noticeable rise in blood pressure among US adults during the COVID-19 pandemic, providing insights into the pandemic’s effect on cardiovascular health. Read more.
- Disruptions in Blood Pressure Control During COVID-19: An article from the American Heart Association highlights how the COVID-19 pandemic has affected blood pressure control, particularly in individuals with hypertension. Read more.
These studies provide valuable insights into how the COVID-19 pandemic has influenced blood pressure levels and hypertension management, underscoring the importance of cardiovascular health during such times.
